astragaloside a has been researched along with fluorouracil in 2 studies
Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
---|---|---|---|---|---|
675 | 5 | 573 | 45,562 | 9,307 | 14,663 |
Protein | Taxonomy | astragaloside a (IC50) | fluorouracil (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
Aromatase | Homo sapiens (human) | 0.63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, C; Wang, PP; Wang, WP; Xu, DJ; Xu, WK | 1 |
Luan, JJ; Wang, L; Wang, PP; Wang, YQ; Xu, DJ; Xu, WK; Yang, CY; Zhu, YH | 1 |
2 other study(ies) available for astragaloside a and fluorouracil
Article | Year |
---|---|
Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Rhodamine 123; Saponins; Triterpenes | 2014 |
Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Saponins; Signal Transduction; Transcription Factor AP-1; Triterpenes | 2017 |